What is a stock summary page? Click here for an overview.
Business Description
Longeveron Inc
NAICS : 541713
SIC : 2833
ISIN : US54303L1044
Share Class Description:
LGVN: Ordinary Shares - Class ADescription
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.29 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -3.03 | |||||
| Beneish M-Score | -1.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -28.3 | |||||
| 3-Year EBITDA Growth Rate | 42.1 | |||||
| 3-Year EPS without NRI Growth Rate | 34.1 | |||||
| 3-Year FCF Growth Rate | 35.1 | |||||
| 3-Year Book Growth Rate | -56.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 52.84 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 136.69 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.1 | |||||
| 9-Day RSI | 51.83 | |||||
| 14-Day RSI | 53.06 | |||||
| 3-1 Month Momentum % | -12.57 | |||||
| 6-1 Month Momentum % | -23.12 | |||||
| 12-1 Month Momentum % | -50.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.6 | |||||
| Quick Ratio | 7.6 | |||||
| Cash Ratio | 7.45 | |||||
| Days Sales Outstanding | 18.37 | |||||
| Days Payable | 531.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -92.5 | |||||
| Shareholder Yield % | -48.41 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.8 | |||||
| Operating Margin % | -690.64 | |||||
| Net Margin % | -667.68 | |||||
| FCF Margin % | -621.24 | |||||
| ROE % | -110.59 | |||||
| ROA % | -82.64 | |||||
| ROIC % | -234.95 | |||||
| 3-Year ROIIC % | -61.25 | |||||
| ROC (Joel Greenblatt) % | -469.69 | |||||
| ROCE % | -105.14 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.39 | |||||
| PB Ratio | 1.16 | |||||
| Price-to-Tangible-Book | 1.3 | |||||
| EV-to-EBIT | -0.48 | |||||
| EV-to-Forward-EBIT | -0.22 | |||||
| EV-to-EBITDA | -0.51 | |||||
| EV-to-Forward-EBITDA | -6.1 | |||||
| EV-to-Revenue | 3.3 | |||||
| EV-to-Forward-Revenue | 3.16 | |||||
| EV-to-FCF | -0.53 | |||||
| Price-to-GF-Value | 0.09 | |||||
| Price-to-Net-Current-Asset-Value | 1.59 | |||||
| Price-to-Net-Cash | 1.63 | |||||
| Earnings Yield (Greenblatt) % | -208.33 | |||||
| FCF Yield % | -58.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LGVN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Longeveron Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.392 | ||
| EPS (TTM) ($) | -4.054 | ||
| Beta | 1.98 | ||
| 3-Year Sharpe Ratio | -0.6 | ||
| 3-Year Sortino Ratio | -0.93 | ||
| Volatility % | 138.65 | ||
| 14-Day RSI | 53.06 | ||
| 14-Day ATR ($) | 0.132125 | ||
| 20-Day SMA ($) | 1.619 | ||
| 12-1 Month Momentum % | -50.8 | ||
| 52-Week Range ($) | 0.7707 - 6.4 | ||
| Shares Outstanding (Mil) | 14.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Longeveron Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Longeveron Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Longeveron Inc Frequently Asked Questions
What is Longeveron Inc(LGVN)'s stock price today?
The current price of LGVN is $1.70. The 52 week high of LGVN is $6.40 and 52 week low is $0.77.
When is next earnings date of Longeveron Inc(LGVN)?
The next earnings date of Longeveron Inc(LGVN) is 2025-05-14 Est..
Does Longeveron Inc(LGVN) pay dividends? If so, how much?
Longeveron Inc(LGVN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers